Pattern and predictors of false positive lymph node involvement on positron emission tomography in patients with non-small cell lung cancer.
THORACIC AND CARDIOVASCULAR SURGEON(2012)
摘要
Objectives The aim of this study was to elucidate the optimal parameters for diagnosing false positive (FP) lymph nodes (LNs) in patients with non-small cell lung cancer. Methods We reviewed 292 patients with non-small cell lung cancer (NSCLC). Fluorodeoxyglucose positron emission tomography (FDG-PET) imaging was performed at 1 hour (early) post-FDG injection and repeated 2 hours (delayed) after injection. We analyzed the relationship between the pathology of LNs and the results of PET, and the percent change in the standardized uptake value (%Delta SUV) between the two time-points. Results Eighteen of 46 cases (39.1%) in the FP group showed higher SUVs for their LNs compared with those for primary tumor, whereas 13.2% in the true positive group (p = 0.032) had higher SUVs for their LNs. Thirty-four of 36 cases in the true positive group had %Delta SUV ranging from 0% to 61.5% compared with only 13 of 33 in the FP group. Twenty out of 22 cases (90.9%) where %Delta SUV was over 61.5% or under 0% were considered as FP. Conclusions Patients with higher SUVs for LNs than for primary tumors and patients with extremely high or low %Delta SUVs tended to have FP LNs.
更多查看译文
关键词
lung cancer treatment (surgery medical),lung cancer diagnosis (includes staging imaging fiducials),positron emission tomography, PET,non-small cell lung cancer,lymph node staging,PET/CT,false positive
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要